Portions of this exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [***], have been separately filed with the Securities and Exchange Commission. THIRD AMENDMENT TO DEVELOPMENT, MANUFACTURING...Development, Manufacturing and Supply Agreement • July 23rd, 2010 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Third Amendment is made effective as of the 2nd day of April, 2008, to the Development, Manufacturing and Supply Agreement made June 28, 2005 (the “Agreement”) by and between Kensey Nash Corporation, a Delaware corporation, having its principal place of business at 735 Pennsylvania Avenue, Exton, PA 18341 (hereinafter “KNC”) and BioMimetic Therapeutics, Inc. (formerly, BioMimetic Pharmaceuticals Inc.), a Delaware corporation, having its principal place of business at 389-A Nichol Mill Lane, Franklin, TN 37067 (hereinafter “BMTI”)(each, individually a “Party” and collectively, the “Parties”).
Portions of this exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [***], have been separately filed with the Securities and Exchange Commission. FIRST AMENDMENT TO DEVELOPMENT, MANUFACTURING...Development, Manufacturing and Supply Agreement • July 23rd, 2010 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
This First Amendment to Development, Manufacturing and Supply Agreement (the “Agreement Amendment”) dated as of August 15, 2006 (the “Effective Date”) between Kensey Nash Corporation, a Delaware corporation, having its principal place of business at 735 Pennsylvania Avenue, Exton, PA 19341 (hereinafter referred to as “KNC”) and BioMimetic Therapeutics, Inc. (formerly, BioMimetic Pharmaceuticals Inc.), a Delaware corporation, having its principal place of business at 389-A Nichol Mill Lane, Franklin, TN 37067 (hereinafter referred to as “BMPI”).
Portions of this exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [***], have been separately filed with the Securities and Exchange Commission. SECOND AMENDMENT TO DEVELOPMENT, MANUFACTURING...Development, Manufacturing and Supply Agreement • July 23rd, 2010 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Second Amendment is made effective as of the first day of November, 2006, to the Development, Manufacturing and Supply Agreement made June 28, 2005 (“the Agreement”) by and between Kensey Nash Corporation, a Delaware corporation, having its principal place of business at 735 Pennsylvania Avenue, Exton, PA 19341 (hereinafter referred to as “KNC”) and BioMimetic Therapeutics, Inc. (formerly, BioMimetic Pharmaceuticals Inc.), a Delaware corporation, having its principal place of business at 389-A Nichol Mill Lane, Franklin, TN 37067 (hereinafter referred to as “BMTI”)(each, individually a “Party” and collectively, the “Parties”).
